Pharmaceutical compositions for relief of covid-19 symptoms and methods of producing and using them
Patent Information
- Application Number
- IL297639
- Authority / Receiving Office
- IL · IL
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-04-28
- Filing Date
- 2021-04-27
- Publication Date
- 2026-08-01
- Estimated Expiration
- 2041-04-27
AI Technical Summary
The COVID-19 pandemic has overwhelmed healthcare facilities with varying symptoms in patients, and while vaccines are available, they are expensive and not universally accessible, with limited efficacy against infection, necessitating symptomatic relief measures.
A pharmaceutical composition comprising a broad-spectrum antibiotic from the tetracycline family, sodium tetraborate decahydrate, Calendula oil, and Echinacea tincture in a liquid carrier, administered in a dosing regimen to provide symptomatic relief for COVID-19 symptoms, including heating glycerin to dissolve sodium borate, then cooling and dispersing the antibiotic and other ingredients.
The composition provides medium to substantial improvement in symptoms within 1.5 days, with a 72% success rate in reducing COVID-19 symptoms, as demonstrated by in vitro and human subject studies, indicating effective symptomatic relief and potential immune modulation.